Cecilia Ganslandt
Cecilia Ganslandt publishes mostly in Pulmonary and Respiratory Medicine, Immunology and Dermatology, on topics such as Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
- World rank
- #3,133,669 of 7,710,434 ranked researchers
- Rank in Denmark
- #23,017 of 43,819
- Works
- 24
- Citations
- 510
- Citations per work
- 21.3
What does Cecilia Ganslandt research?
Cecilia Ganslandt's work is mostly in Medicine (58%), Immunology and Microbiology (16%), Pharmacology, Toxicology and Pharmaceutics (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1457.7%
- Medicine1457.7%
- Everything else624.0%
- Life Sciences418.3%
- 1Pulmonary and Respiratory Medicine35% of their works
- 2Immunology16% of their works
- 3Dermatology13% of their works
- 4Rheumatology7% of their works
- 5Epidemiology3% of their works
- 6Pharmaceutical Science3% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Neonatal Respiratory Health Research
- Spondyloarthritis Studies and Treatments
- Advancements in Transdermal Drug Delivery
- Mycobacterium research and diagnosis
Which keywords describe Cecilia Ganslandt's research?
The keywords of their largest research topics: TGF-ß, Pulmonary Hypertension, IL-17, TH17 Cells, Filaggrin, Skin Microbiome, Fibrosis and Idiopathic Pulmonary Fibrosis.
- Solid Lipid Nanoparticles
- Mycobacterium avium
- Spondyloarthritis
- Bronchopulmonary Dysplasia
- Right Heart Assessment
- Idiopathic Pulmonary Fibrosis
- Skin Microbiome
- TH17 Cells
- Pulmonary Hypertension
- TGF-ß
- IL-17
- Filaggrin
- Fibrosis
- Echocardiography
- Ankylosing Spondylitis
- Preterm Infants
- Microneedles
- Nontuberculous Mycobacteria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- TGF-ß182 topics
- Pulmonary Hypertension112 topics
- IL-17101 topic
- TH17 Cells101 topic
- Filaggrin91 topic
- Skin Microbiome91 topic
- Fibrosis81 topic
- Idiopathic Pulmonary Fibrosis81 topic
- Echocardiography71 topic
- Right Heart Assessment71 topic
- Ankylosing Spondylitis41 topic
- Bronchopulmonary Dysplasia41 topic
- Preterm Infants41 topic
- Spondyloarthritis41 topic
- Microneedles21 topic
- Mycobacterium avium21 topic
- Nontuberculous Mycobacteria21 topic
- Solid Lipid Nanoparticles21 topic
Where does Cecilia Ganslandt work?
Cecilia Ganslandt's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.
How many publications and citations does Cecilia Ganslandt have?
OpenAlex counts 24 works and 510 citations for Cecilia Ganslandt, an h-index of 10, ranking #3,133,669 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Cecilia Ganslandt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.